Any current/future new fundraising through debt or equity?

The company has board approval for a rights issue aiming to raise Rs.300 Crores. The rights issue is in progress; due diligence is underway and will be submitted to the regulatory authority. Management has requested more time to close the rights issue but confirmed it is on track. On debt, current net debt stands at Rs.117 Crores consolidated with cash around Rs.75 Crores. Recent cash drawdown was primarily for expansion strategies; the company is deploying resources towards growth. Management indicated current cash flow is sufficient, and no immediate need for additional cash infusion was not

Any current/future capex/capital investment/strategic investment?

Kaya Limited is actively investing in upgrading clinic infrastructure, reflected by renovating 11 clinics YTD and relocating 4 clinics in the year, with relocated clinics seeing 73% growth this quarter. Refurbishment costs per clinic vary from under Rs.10 lakhs for simple refurbishments up to Rs.70-80 lakhs for relocations, depending on size and complexity. The company invested in 39 new derma technology machines in Q3, including anti-aging, acne scar, and hair care devices, totaling 102 new machines added recently. Focus on improving clinic technology and customer experience with significant

Future growth expectations in sales/revenue/volumes?

Kaya India is experiencing strong revenue growth, with clinic growth at 19% YoY and 17% YTD. Product business growth is robust at 24% YTD, driven by hair care, skincare, nutraceuticals, and omni-channel initiatives. Renovation and relocation of clinics are leading to higher collections, with relocated clinics growing 73% in Q3 and renovated clinics growing 16% YTD. New verticals like body treatments contribute around 6% of business, showing strong traction. Expansion into tier 2 cities and suburban areas is ongoing, with 4 clinics opened under a new model and plans to open 6-8 clinics in the s

Future growth expectations in earnings/operating earnings/profits/EPS?

Kaya has shown positive momentum with double-digit growth in India clinics (19% YoY) and product growth of 26% YoY in Q3 FY2024. EBITDA improved significantly, with a 67% increase in Q3 to Rs.11.2 Crores and narrowing loss after tax to Rs.9 Crores from Rs.17.6 Crores last year. The company is pursuing sustainable growth via clinic renovations, new technology investments, and expanding product lines (nutraceuticals, hair care, body vertical). Management indicates a path to profitability if current growth trends continue but refrains from giving exact timelines. Expansion into tier 2 cities and

Kaya LtdQ3 FY24Leisure Services

Kaya Ltd Q3 FY24 Earnings Call Analysis

Revenue, margin, capex, fundraise and order book outlook from management commentary.

Price: ₹312.4Market Cap: ₹474 CrSector: Leisure Services

Management growth scorecard

Revenue

Category 3

Margin

Category 3

Fundraise

Yes

Order

N/A

Capex

Yes

2 of 4 growth signals are positive.

Full analysis

Revenue guidance

Category 3

Kaya India is experiencing strong revenue growth, with clinic growth at 19% YoY and 17% YTD.
Product business growth is robust at 24% YTD, driven by hair care, skincare, nutraceuticals, and omni-channel initiatives.
Renovation and relocation of clinics are leading to higher collections, with relocated clinics growing 73% in Q3 and renovated clinics growing 16% YTD.
New verticals like body treatments contribute around 6% of business, showing strong traction.
Expansion into tier 2 cities and suburban areas is ongoing, with 4 clinics opened under a new model and plans to open 6-8 clinics in the short term.
Investment in technology and customer experience is expected to sustain growth.
Focus on product growth with new launches and nutraceuticals, targeting higher product sales contribution over medium term.
Management anticipates continued growth and eventually turning profitable if the current trajectory sustains.

Margin guidance

Category 3

Kaya has shown positive momentum with double-digit growth in India clinics (19% YoY) and product growth of 26% YoY in Q3 FY2024.
EBITDA improved significantly, with a 67% increase in Q3 to Rs.11.2 Crores and narrowing loss after tax to Rs.9 Crores from Rs.17.6 Crores last year.
The company is pursuing sustainable growth via clinic renovations, new technology investments, and expanding product lines (nutraceuticals, hair care, body vertical).
Management indicates a path to profitability if current growth trends continue but refrains from giving exact timelines.
Expansion into tier 2 cities and omni-channel retail is expected to diversify revenue streams and improve margins.
New verticals and increased customer acquisition efforts aim to boost top-line and eventually improve EPS.
Rights issue underway to raise Rs.300 Crores to fuel expansion and strengthen balance sheet.
Overall, with continued execution, Kaya is likely to turn PAT positive in the near future.

See what Kaya Ltd management said on margin guidance — free account, 30 seconds.

Fundraise plans

Yes

The company has board approval for a rights issue aiming to raise Rs.300 Crores.
The rights issue is in progress; due diligence is underway and will be submitted to the regulatory authority.
Management has requested more time to close the rights issue but confirmed it is on track.
On debt, current net debt stands at Rs.117 Crores consolidated with cash around Rs.75 Crores.
Recent cash drawdown was primarily for expansion strategies; the company is deploying resources towards growth.
Management indicated current cash flow is sufficient, and no immediate need for additional cash infusion was noted.

Order book

The transcript provided does not explicitly mention current or expected order book or pending orders for Kaya Limited. However, relevant insights related to growth, expansion, and business traction include: - Kaya India clinics experienced strong growth with 19% revenue growth in Q3 and 17% YTD. - The company renovated 11 clinics YTD and relocated 4 clinics, with renovated clinics showing 16% growth. - Around 6 to 8 new clinics planned for the short term. - Expansion focus on Tier 2 cities and suburban clusters with ongoing identification of new clinic locations. - Continued investment in product business with 24% growth over last 9-10 months, including D2C and omni-channel. - No specific quantitative details provided on order book or pending orders. Therefore, no explicit order book or pending orders data is disclosed in this call.

See what Kaya Ltd management said on order book — free account, 30 seconds.

Capex plans

Yes

Kaya Limited is actively investing in upgrading clinic infrastructure, reflected by renovating 11 clinics YTD and relocating 4 clinics in the year, with relocated clinics seeing 73% growth this quarter.
Refurbishment costs per clinic vary from under Rs.10 lakhs for simple refurbishments up to Rs.70-80 lakhs for relocations, depending on size and complexity.
The company invested in 39 new derma technology machines in Q3, including anti-aging, acne scar, and hair care devices, totaling 102 new machines added recently.
Focus on improving clinic technology and customer experience with significant investments in contemporary technology and machines post-COVID.
Strategy includes expanding footprint by adding 6-8 new clinics in the short term, primarily in tier 2 cities and suburbs of major cities.
Ongoing investment in the D2C and omni-channel product business, including development of own nutraceutical brand.

Track Kaya Ltd — get its next earnings analysis in your feed

How does Kaya Ltd rank vs peers in Leisure Services?

Pro feature

ThisKaya Ltd

Rev 3Mar 3

See where Kaya Ltd sits in Leisure ServicesSee which companies these are, and every other name in the sector.Open rankings

How does Kaya Ltd rank in Leisure Services?

Compare Kaya Ltd against every Leisure Services company (Q3 FY24) on revenue, margins and earnings-call signals.

View Leisure Services leaderboard →

What Kaya Ltd's management said in earlier quarters

Others in Leisure Services this season

Delta Corp (Q2 FY27)
For the quarter ended 30th September 2026, consolidated net sales/revenue from operations was ₹159.34 crores, down from ₹182.76 crores in the same quarter last…
Le Travenues Technology Ltd (Q2 FY27)
Gross Transaction Value (GTV): ₹5,304.47 crores, up 22% YoY . Key investor presentation takeaways from Le Travenues Technology Ltd's Q2 FY27 investor presentati
Ventive Hospitality Ltd (Q2 FY26)
Direct booking channels growing, especially in India (currently 60% of sales) and Maldives, enhancing margins and revenues. Key concall takeaways from Ventive…
Imagicaaworld Entertainment Ltd (Q2 FY26)
41.8 Cr, up 4.6% from Rs. Key investor presentation takeaways from Imagicaaworld Entertainment Ltd's Q2 FY26 investor presentation — and how it ranks against se

Compare:vs Indian Hotels Co Ltd vs Indian Railway Catering & Tourism Corporation Ltd vs ITC Hotels

🔎 Who's planning the most growth?

Companies ranked by management's own guidance — revenue, margins, capex and order book, from every earnings call in India.

See rankings →

Kaya Ltd Q3 FY24 Earnings Call Analysis

Revenue guidance

Fundraise plans

Capex plans

How does Kaya Ltd rank in Leisure Services?

Continue your research

What Kaya Ltd's management said in earlier quarters

Others in Leisure Services this season